Oh J - Search Results

1

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.

Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. Oh J, et al. Cell. 2001 Dec 14;107(6):789-800. doi: 10.1016/s0092-8674(01)00597-9. Cell. 2001. PMID: 11747814 Free article.

2

RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling.

Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C. Noda M, et al. Among authors: oh j. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):167-75. doi: 10.1023/a:1023043315031. Cancer Metastasis Rev. 2003. PMID: 12784995 Review.

3

Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice.

Oh J, Takahashi R, Adachi E, Kondo S, Kuratomi S, Noma A, Alexander DB, Motoda H, Okada A, Seiki M, Itoh T, Itohara S, Takahashi C, Noda M. Oh J, et al. Oncogene. 2004 Jun 24;23(29):5041-8. doi: 10.1038/sj.onc.1207688. Oncogene. 2004. PMID: 15064723

4

The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors.

Echizenya M, Kondo S, Takahashi R, Oh J, Kawashima S, Kitayama H, Takahashi C, Noda M. Echizenya M, et al. Among authors: oh j. Oncogene. 2005 Sep 1;24(38):5850-7. doi: 10.1038/sj.onc.1208733. Oncogene. 2005. PMID: 16007210

5

Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells.

Kondo S, Shukunami C, Morioka Y, Matsumoto N, Takahashi R, Oh J, Atsumi T, Umezawa A, Kudo A, Kitayama H, Hiraki Y, Noda M. Kondo S, et al. Among authors: oh j. J Cell Sci. 2007 Mar 1;120(Pt 5):849-57. doi: 10.1242/jcs.03388. Epub 2007 Feb 13. J Cell Sci. 2007. PMID: 17298979

6

Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice.

Chandana EP, Maeda Y, Ueda A, Kiyonari H, Oshima N, Yamamoto M, Kondo S, Oh J, Takahashi R, Yoshida Y, Kawashima S, Alexander DB, Kitayama H, Takahashi C, Tabata Y, Matsuzaki T, Noda M. Chandana EP, et al. Among authors: oh j. BMC Dev Biol. 2010 Aug 6;10:84. doi: 10.1186/1471-213X-10-84. BMC Dev Biol. 2010. PMID: 20691046 Free PMC article.

7

Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes.

Izumi H, Takahashi C, Oh J, Noda M. Izumi H, et al. Among authors: oh j. FEBS Lett. 2000 Sep 8;481(1):31-6. doi: 10.1016/s0014-5793(00)01902-5. FEBS Lett. 2000. PMID: 10984610 Free article.

8

Transcriptional control of the RECK metastasis/angiogenesis suppressor gene.

Sasahara RM, Brochado SM, Takahashi C, Oh J, Maria-Engler SS, Granjeiro JM, Noda M, Sogayar MC. Sasahara RM, et al. Among authors: oh j. Cancer Detect Prev. 2002;26(6):435-43. doi: 10.1016/s0361-090x(02)00123-x. Cancer Detect Prev. 2002. PMID: 12507228 Review.

9

TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118.

Oh J, Diaz T, Wei B, Chang H, Noda M, Stetler-Stevenson WG. Oh J, et al. Oncogene. 2006 Jul 13;25(30):4230-4. doi: 10.1038/sj.onc.1209444. Epub 2006 Feb 20. Oncogene. 2006. PMID: 16491114 Free PMC article.

10

Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK.

Oh J, Seo DW, Diaz T, Wei B, Ward Y, Ray JM, Morioka Y, Shi S, Kitayama H, Takahashi C, Noda M, Stetler-Stevenson WG. Oh J, et al. Cancer Res. 2004 Dec 15;64(24):9062-9. doi: 10.1158/0008-5472.CAN-04-1981. Cancer Res. 2004. PMID: 15604273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,363 results

Search Page

Filters